Welcome to Skilled in the Art. I'm Law.com IP reporter Scott Graham. Here's what's shaking this week.

• Exela Pharma Sciences will get more than three years out of its patents on injectable cysteine, thanks to a Fish & Richardson trial team.

•  A Cisco competitor's six-year journey to a jury trial ends in a finding of non-infringement.